Dr. Maeve O’Connor, Recognized as One of the Best Doctors in America, Joins
SRxA as an Advisor to Its Allergy Group
Washington, DC, May 03, 2011 --(PR.com)-- Strategic Pharmaceutical Advisors (SRxA), a leading U.S.
healthcare strategic marketing consulting and education firm, is delighted to announce that Maeve
O'Connor, MD, FACAAI, FAAAAI has become an independent clinical Advisor to its Allergy Group.
Dr. O'Connor practices at the Carolina Asthma and Allergy Center, a synergetic regional care center that
sees over 10,000 new patients and provides ongoing care to more than 22,000 existing patients annually.
She is also an Adjunct Assistant Professor in the Department of Public Health Sciences at UNC Charlotte,
Dr. O'Connor earned her MD degree at the University of South Carolina School of Medicine, and
completed her internship and residency at the University of Texas and Affiliated Hospitals in Houston,
She served as Chief Medical Resident for one year in Texas prior to moving to Denver, CO, where she
completed her Fellowship training at the National Jewish Medical and Research Center and the
University of Colorado Health Sciences Center. She is Board Certified by both the American Board of
Internal Medicine and the American Board of Allergy and Immunology.
Dr. O'Connor is a Fellow of both the American Academy of Asthma Allergy and Immunology and the
American College of Asthma Allergy and Immunology. She serves as President-Elect for the
Southeastern Allergy Society and is a member of the Clinical Immunology Society, the American
Medical Association and the North Carolina Medical Society. She is the President-Elect of the
Mecklenburg County Medical Society and serves on several committees. She has been selected by her
peers to be included in the Best Doctors of America 2011-2012 Database. Dr. O'Connor has been one of
Charlotte Magazine's "Top Doctors" for both Adult Allergy/Immunology and Pediatric
Allergy/Immunology from 2007 to2010.
Dr. O'Connor is a member of the Food Allergy and Anaphylaxis Network, the American Latex Allergy
Association, and the Primary Immunodeficiency Foundation. She has published research articles on
desensitization immunotherapy, asthma, and food allergy. She is currently involved in clinical research
and is a preceptor for Pediatric, Family Medicine and Internal Medicine residents at Carolinas Healthcare
Systems. She is one of the medical advisors for Parents of Allergic Kids, a support and resource group
started by parents of food allergic children.
“I am delighted to become an Advisor to SRxA and to support and contribute to the valuable educational
projects and initiatives developed by this group,” commented Dr. O'Connor.
Dr. Christos Efessiou, CEO of SRxA, said “I am very pleased that Dr. O'Connor has joined our team of
Allergy Advisors. She is a leading member of the new generation of Key Opinion Leaders and practicing
specialists in this field. Her involvement as an Advisor to SRxA brings new perspectives and energy to
SRxA operates on a unique business model that utilizes independent clinical teams of national and
international Key Opinion Leaders who advise pharmaceutical and medical device clients in research,
clinical, regulatory, education and business matters.
Strategic Allergy Advisors is a network of experts specializing in allergy, asthma, and clinical
immunology, and is one of a growing number of specialties under the SRxA umbrella. In this group, Dr.
O'Connor joins other Leaders in the field including Drs. Eli Meltzer, Michael Kaliner, Bradley Chipps,
William Storms, Michael Foggs, Allan Luskin, John Oppenheimer, Sheldon Spector, Don Bukstein,
Warner Carr, Russell Settipane and Todd Mahr.
In addition to Allergy, other SRxA advisor groups focus in key therapeutic areas such as Pulmonary
Diseases, Otolaryngology, Respiratory Medicine (Europe), Ophthalmology, Reproductive Endocrinology
and Genetics, Ocular Medicine and Surgery, Aesthetics, and Behavioral Health. The company is
headquartered in Washington, DC with offices in London and Hong Kong.
For more information, please contact Judi Miller at 202.316.8692 or jmiller@SRxA.com, or visit
SRxA Strategic Pharmaceutical Advisors, LLC
Online Version of Press Release:
You can read the online version of this press release at: http://www.pr.com/press-release/318100